Strata Critical Medical (SRTA) Total Liabilities (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Total Liabilities data on file, last reported at $41.9 million in Q1 2026.

• Quarterly Total Liabilities rose 35.92% year-over-year to $41.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.9 million (up 35.92% YoY) and the FY2025 annual result came in at $46.4 million, up 33.58% from the prior year.
• Total Liabilities fell to $41.9 million in Q1 2026 per SRTA's latest filing, from $46.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $60.6 million in Q4 2023 and bottomed at $30.8 million in Q1 2025.
• The 5-year median for Total Liabilities is $46.4 million (2025), against an average of $46.2 million.
• The widest annual swing landed in 2023, when Total Liabilities soared 86.29%; it then tumbled 42.71% in 2024.
• Tracing SRTA's Total Liabilities over 5 years: stood at $50.5 million in 2022, then rose by 19.99% to $60.6 million in 2023, then plunged by 42.71% to $34.7 million in 2024, then soared by 33.58% to $46.4 million in 2025, then fell by 9.73% to $41.9 million in 2026.
• Per Business Quant, the three latest SRTA Total Liabilities figures stand at $41.9 million (Q1 2026), $46.4 million (Q4 2025), and $52.1 million (Q3 2025).

Peer Comparison